238 related articles for article (PubMed ID: 15508059)
41. An open-labelled study of granulocyte colony-stimulating factor in the treatment of active Crohn's disease.
Korzenik JR; Dieckgraefe BK
Aliment Pharmacol Ther; 2005 Feb; 21(4):391-400. PubMed ID: 15709989
[TBL] [Abstract][Full Text] [Related]
42. [Recurrent aseptic osteonecrosis in Crohn's disease - extraintestinal manifestation or steroid related complication?].
Lanyi B; Dienes HP; Kruis W
Dtsch Med Wochenschr; 2005 Aug; 130(34-35):1944-7. PubMed ID: 16123897
[TBL] [Abstract][Full Text] [Related]
43. Localised gastrocnemius myositis in Crohn's disease.
Christopoulos C; Savva S; Pylarinou S; Diakakis A; Papavassiliou E; Economopoulos P
Clin Rheumatol; 2003 May; 22(2):143-5. PubMed ID: 12740681
[TBL] [Abstract][Full Text] [Related]
44. Metastatic vulval Crohn's disease and infliximab: a case report.
Tritton SM; Whyte L; Fischer G
J Reprod Med; 2009 Jan; 54(1):41-4. PubMed ID: 19263879
[TBL] [Abstract][Full Text] [Related]
45. [Recurrence of Crohn's disease after surgery--causes and risks].
Mirow L; Hauenschild L; Hildebrand P; Kleemann M; Keller R; Franke C; Roblick UJ; Bruch HP; Kujath P
Zentralbl Chir; 2008 Apr; 133(2):182-7. PubMed ID: 18415909
[TBL] [Abstract][Full Text] [Related]
46. A case of acute loss of vision as the presenting symptom of Crohn's disease.
Girardin M; Waschke KA; Seidman EG
Nat Clin Pract Gastroenterol Hepatol; 2007 Dec; 4(12):695-8. PubMed ID: 18043679
[TBL] [Abstract][Full Text] [Related]
47. Fistulating anal Crohn's disease: results of combined surgical and infliximab treatment.
Hyder SA; Travis SP; Jewell DP; McC Mortensen NJ; George BD
Dis Colon Rectum; 2006 Dec; 49(12):1837-41. PubMed ID: 17041753
[TBL] [Abstract][Full Text] [Related]
48. Budesonide and prednisolone suppress peripheral blood natural killer cells in Crohn's disease.
Van Ierssel AJ; Van der Sluys Veer A; Verspaget HW; Griffioen G; Van Hogezand RA; Lamers CB
Aliment Pharmacol Ther; 1995 Apr; 9(2):173-8. PubMed ID: 7605858
[TBL] [Abstract][Full Text] [Related]
49. Long-term treatment of high intestinal output syndrome with budesonide in patients with Crohn's disease and ileostomy.
Ecker KW; Stallmach A; Löffler J; Greinwald R; Achenbach U
Dis Colon Rectum; 2005 Feb; 48(2):237-42. PubMed ID: 15714248
[TBL] [Abstract][Full Text] [Related]
50. Oral ulcerations as a sign of Crohn's disease in a pediatric patient: a case report.
Stavropoulos F; Katz J; Guelmann M; Bimstein E
Pediatr Dent; 2004; 26(4):355-8. PubMed ID: 15344631
[TBL] [Abstract][Full Text] [Related]
51. Paediatric inflammatory bowel disease in New Zealand.
Yap J; Wesley A; Mouat S; Chin S
N Z Med J; 2008 Oct; 121(1283):19-34. PubMed ID: 18841182
[TBL] [Abstract][Full Text] [Related]
52. Budesonide (Entocort EC) for Crohn's disease.
Med Lett Drugs Ther; 2002 Jan; 44(1122):6-8. PubMed ID: 11856950
[No Abstract] [Full Text] [Related]
53. Efficacy of topical metronidazole (10 percent) in the treatment of anorectal Crohn's disease.
Stringer EE; Nicholson TJ; Armstrong D
Dis Colon Rectum; 2005 May; 48(5):970-4. PubMed ID: 15785894
[TBL] [Abstract][Full Text] [Related]
54. Monozygotic twins with Crohn's disease: a case report.
Klein GL; Ament ME; Sparkes RS
Gastroenterology; 1980 Nov; 79(5 Pt 1):931-3. PubMed ID: 7191382
[TBL] [Abstract][Full Text] [Related]
55. Pharmacokinetics of budesonide (Entocort EC) capsules for Crohn's disease.
Edsbäcker S; Andersson T
Clin Pharmacokinet; 2004; 43(12):803-21. PubMed ID: 15355126
[TBL] [Abstract][Full Text] [Related]
56. The impact of major depressive disorder on the short- and long-term outcome of Crohn's disease treatment with infliximab.
Persoons P; Vermeire S; Demyttenaere K; Fischler B; Vandenberghe J; Van Oudenhove L; Pierik M; Hlavaty T; Van Assche G; Noman M; Rutgeerts P
Aliment Pharmacol Ther; 2005 Jul; 22(2):101-10. PubMed ID: 16011668
[TBL] [Abstract][Full Text] [Related]
57. A single center experience of methotrexate in the treatment of Crohn's disease and ulcerative colitis: a case for subcutaneous administration.
Nathan DM; Iser JH; Gibson PR
J Gastroenterol Hepatol; 2008 Jun; 23(6):954-8. PubMed ID: 17559377
[TBL] [Abstract][Full Text] [Related]
58. Crohn's disease of the esophagus.
Maffei VJ; Zaatari GS; McGarity WC; Mansour KA
J Thorac Cardiovasc Surg; 1987 Aug; 94(2):302-5. PubMed ID: 3613631
[TBL] [Abstract][Full Text] [Related]
59. Two-year combination antibiotic therapy with clarithromycin, rifabutin, and clofazimine for Crohn's disease.
Selby W; Pavli P; Crotty B; Florin T; Radford-Smith G; Gibson P; Mitchell B; Connell W; Read R; Merrett M; Ee H; Hetzel D;
Gastroenterology; 2007 Jun; 132(7):2313-9. PubMed ID: 17570206
[TBL] [Abstract][Full Text] [Related]
60. Crohn's disease of the esophagus: case report and review of the literature.
Freedman PG; Dieterich DT; Balthazar EJ
Am J Gastroenterol; 1984 Nov; 79(11):835-8. PubMed ID: 6507403
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
